Charles River Labs Licenses Luminex s xMap Technology
Jan 06, 2006
NEW YORK, Dec. 6 (GenomeWeb News) - Charles River Labs has licensed Luminex's xMAP technology for use within its research models and services, the companies said yesterday.
Luminex's xMAP technology enables multiple assays to be performed in a single well using suspended beads.
A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.
A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.
In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.